New type of effective antifungal treatment identified.
Bosch
Xavier
X
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000077336:Caspofungin; D054714:Echinocandins; D005334:Fever; D006801:Humans; D007262:Infusions, Intravenous; D055666:Lipopeptides; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000150:complications; D010456:Peptides, Cyclic / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077336:Caspofungin